Effect of two days treatment with orlistat on plasma leptin in obese patients without weight loss

Objective: Little is known about the impact of orlistat on the leptin system. We studied the plasma leptin and satiety sensation response for two days of orlistat treatment without hypocaloric diet and weight loss. Material and methods: Twenty obese female subjects were recruited from our medical ou...

Full description

Bibliographic Details
Main Authors: Ana Rodríguez-Valle, María Ángeles Navarro-Ferrando, Diana Boj-Carceller, Jesús Fernando Escanero-Marcén, Alejandro Sanz-Paris
Format: Article
Language:English
Published: Arán Ediciones, S. L.
Series:Nutrición Hospitalaria
Subjects:
Online Access:http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112016000200017&lng=en&tlng=en
id doaj-01d372d2718e4a8b948ee1a1bbe3da4e
record_format Article
spelling doaj-01d372d2718e4a8b948ee1a1bbe3da4e2020-11-24T21:34:57ZengArán Ediciones, S. L.Nutrición Hospitalaria0212-161133229229710.20960/nh.106S0212-16112016000200017Effect of two days treatment with orlistat on plasma leptin in obese patients without weight lossAna Rodríguez-Valle0María Ángeles Navarro-Ferrando1Diana Boj-Carceller2Jesús Fernando Escanero-Marcén3Alejandro Sanz-Paris4Hospital Universitario Miguel Servet de ZaragozaUniversidad de ZaragozaHospital Universitario Miguel Servet de ZaragozaUniversidad de ZaragozaHospital Universitario Miguel Servet de ZaragozaObjective: Little is known about the impact of orlistat on the leptin system. We studied the plasma leptin and satiety sensation response for two days of orlistat treatment without hypocaloric diet and weight loss. Material and methods: Twenty obese female subjects were recruited from our medical outpatient clinics. All of these subjects had previously received advice on dietary restriction and lifestyle modification, but remained obese with a stable body weight for at least six months before recruitment for the study. Results: Subjects were given 120 mg orlistat 3 times daily and were asked to maintain their usual diet. At baseline and two days after the treatment with orlistat, physical examination, hunger and blood analysis were repeated. There were no significant differences observed regarding energy dietary intake, body weight and waist-hip ratio, or in plasma glucose, insulin c-peptide concentrations. Only plasma leptin and triglycerides concentrations decreased (p: 0.0001 and 0.01 respectively). Decrease in plasma leptin concentration was positively correlated with changes observed in plasma triglycerides concentration (p: 0.01, r2: 0.45). Pre-dinner hunger increased and was negatively correlated with decrease in leptin (p: 0.0001, r2: 0.74) and triglycerides (p: 0.02, r2: 0.59). Conclusion: These data suggest that the partial fat malabsorption induced by the treatment with orlistat quickly reduces plasma triglycerides and leptin. This decrease is associated with increased appetite before intake following the main meal of the day.http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112016000200017&lng=en&tlng=enLeptinaOrlistatTriglicéridosObesidadSociedad
collection DOAJ
language English
format Article
sources DOAJ
author Ana Rodríguez-Valle
María Ángeles Navarro-Ferrando
Diana Boj-Carceller
Jesús Fernando Escanero-Marcén
Alejandro Sanz-Paris
spellingShingle Ana Rodríguez-Valle
María Ángeles Navarro-Ferrando
Diana Boj-Carceller
Jesús Fernando Escanero-Marcén
Alejandro Sanz-Paris
Effect of two days treatment with orlistat on plasma leptin in obese patients without weight loss
Nutrición Hospitalaria
Leptina
Orlistat
Triglicéridos
Obesidad
Sociedad
author_facet Ana Rodríguez-Valle
María Ángeles Navarro-Ferrando
Diana Boj-Carceller
Jesús Fernando Escanero-Marcén
Alejandro Sanz-Paris
author_sort Ana Rodríguez-Valle
title Effect of two days treatment with orlistat on plasma leptin in obese patients without weight loss
title_short Effect of two days treatment with orlistat on plasma leptin in obese patients without weight loss
title_full Effect of two days treatment with orlistat on plasma leptin in obese patients without weight loss
title_fullStr Effect of two days treatment with orlistat on plasma leptin in obese patients without weight loss
title_full_unstemmed Effect of two days treatment with orlistat on plasma leptin in obese patients without weight loss
title_sort effect of two days treatment with orlistat on plasma leptin in obese patients without weight loss
publisher Arán Ediciones, S. L.
series Nutrición Hospitalaria
issn 0212-1611
description Objective: Little is known about the impact of orlistat on the leptin system. We studied the plasma leptin and satiety sensation response for two days of orlistat treatment without hypocaloric diet and weight loss. Material and methods: Twenty obese female subjects were recruited from our medical outpatient clinics. All of these subjects had previously received advice on dietary restriction and lifestyle modification, but remained obese with a stable body weight for at least six months before recruitment for the study. Results: Subjects were given 120 mg orlistat 3 times daily and were asked to maintain their usual diet. At baseline and two days after the treatment with orlistat, physical examination, hunger and blood analysis were repeated. There were no significant differences observed regarding energy dietary intake, body weight and waist-hip ratio, or in plasma glucose, insulin c-peptide concentrations. Only plasma leptin and triglycerides concentrations decreased (p: 0.0001 and 0.01 respectively). Decrease in plasma leptin concentration was positively correlated with changes observed in plasma triglycerides concentration (p: 0.01, r2: 0.45). Pre-dinner hunger increased and was negatively correlated with decrease in leptin (p: 0.0001, r2: 0.74) and triglycerides (p: 0.02, r2: 0.59). Conclusion: These data suggest that the partial fat malabsorption induced by the treatment with orlistat quickly reduces plasma triglycerides and leptin. This decrease is associated with increased appetite before intake following the main meal of the day.
topic Leptina
Orlistat
Triglicéridos
Obesidad
Sociedad
url http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112016000200017&lng=en&tlng=en
work_keys_str_mv AT anarodriguezvalle effectoftwodaystreatmentwithorlistatonplasmaleptininobesepatientswithoutweightloss
AT mariaangelesnavarroferrando effectoftwodaystreatmentwithorlistatonplasmaleptininobesepatientswithoutweightloss
AT dianabojcarceller effectoftwodaystreatmentwithorlistatonplasmaleptininobesepatientswithoutweightloss
AT jesusfernandoescaneromarcen effectoftwodaystreatmentwithorlistatonplasmaleptininobesepatientswithoutweightloss
AT alejandrosanzparis effectoftwodaystreatmentwithorlistatonplasmaleptininobesepatientswithoutweightloss
_version_ 1725947226593689600